2D-BioPAD presented at the Hybrid Scientific Symposium on Dementia Prevention
Our partner Alzheimer Hellas, together with the Panhellenic Institute of Neurodegenerative Diseases and the School of Medicine of...
Read more
Supple Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer’s Disease.
Learn moreIn a Nutshell
2D-BioPAD is pioneering a graphene-based Point-of-Care (PoC) In-Vitro Diagnostics (IVD) system for early Alzheimer’s Disease (AD) detection. This non-invasive solution, using 2D materials, can identify and quantify up to 5 AD biomarkers in real-time. Clinical pilot studies in Finland, Greece, and Germany aim to demonstrate its impact, with a focus on safety, ethics, and seamless integration into primary healthcare settings.
Latest News
2D-BioPAD at the Kuopio Neuroscience 50 Years Symposium
2D-BioPAD was proudly presented at the Kuopio Neuroscience 50 Years Symposium, a landmark event celebrating five decades of...
Read more
2D-BioPAD was featured at the conference “Wine and Olive Oil in the Mediterranean”
2D-BioPAD was featured at the international conference “Wine and Olive Oil in the Mediterranean”, held in Ancient Olympia,...
Read more
2D-BioPAD Business Model Validation Workshop
The 2D-BioPAD consortium successfully organised a dedicated workshop focused on validating and refining the project’s business models for...
Read more
Consortium Partners
